Incannex Healthcare (IXHL) Depreciation & Amortization (CF) (2023 - 2026)

Incannex Healthcare (IXHL) posted quarterly Depreciation & Amortization (CF) of $65000.0 for Q1 2026, up 1400.0% year-on-year from $4333.3 in Q1 2025, and up 10.17% on a QoQ basis from $59000.0 in Q4 2025.

Incannex Healthcare (IXHL) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends

Incannex Healthcare (IXHL) has reported Depreciation & Amortization (CF) for 4 consecutive years, with $65000.0 the latest figure, recorded in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 1400.0% year-over-year to $65000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $251000.0 (up 1.62% YoY) and the FY2025 annual result came in at $246000.0, up 138.83% from the prior year.
  • Depreciation & Amortization (CF) improved to $65000.0 in Q1 2026 per IXHL's latest filing, from $59000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for IXHL reached as high as $126000.0 in Q4 2024 and fell as low as -$13000.0 in Q1 2023.
  • A 4-year average of $45538.5 and a median of $61000.0 in 2025 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2025 — Depreciation & Amortization (CF) slumped 129.41% — and 2026, when it soared 1400.0%.
  • Year by year, Depreciation & Amortization (CF) stood at $12000.0 in 2023, then jumped by 950.0% to $126000.0 in 2024, then plunged by 53.17% to $59000.0 in 2025, then rose by 10.17% to $65000.0 in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $65000.0, $59000.0, and $66000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Incannex Healthcare 3.63 Mn 3.63 Mn - 65,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 65,000.00
Mar 31, 2026 65,000.00
Dec 31, 2025 59,000.00
Dec 31, 2025 59,000.00
Sep 30, 2025 66,000.00
Sep 30, 2025 66,000.00
Jun 30, 2025 61,000.00
Jun 30, 2025 61,000.00
Mar 31, 2025 -5,000.00
Mar 31, 2025 -5,000.00
Dec 31, 2024 126,000.00
Dec 31, 2024 126,000.00
Sep 30, 2024 64,000.00
Sep 30, 2024 64,000.00
Jun 30, 2024 62,000.00
Jun 30, 2024 62,000.00
Mar 31, 2024 17,000.00
Mar 31, 2024 17,000.00
Dec 31, 2023 12,000.00
Dec 31, 2023 12,000.00